Addition Of A Sleeve To The Etanercept Autoinjector (Enbrel^® MyClic^®) Improves Ease Of Use In Patients With Rheumatoid Arthritis

Figures & data

Table 1 Patient Characteristics

	Number (%) Of Participants, N = 24
Female	16 (67)
Age (years)
20–29	3 (13)
30–39	3 (13)
40–49	4 (17)
50–59	3 (13)
60–69	7 (29)
70–79	4 (17)
Current RA medication
Etanercept (via autoinjector)	6 (25)
Other biologic (via autoinjector)	9 (38)
Non-biologic DMARD	9 (38)
Level of dexterity impairment^a
Mild	10 (42)
Moderate	2 (8)
Severe	12 (50)

Notes: ^aBased on results of grip strength and Purdue Peg Board tests. Percentages may not add up to 100 owing to rounding.

Abbreviations: DMARD, disease-modifying anti-inflammatory drug; RA, rheumatoid arthritis.

Figure 1 Average scores given by participants. Participants rated attributes on scales of 1 to 7, where 1 = not at all easy and 7 = extremely easy (overall use, ease of preparation, ease of administration, ease of learning to use) or 1 = not at all positive and 7 = extremely positive (look, feel, size and overall experience).

Figure 2 Comparison of the Enbrel^® MyClic^® autoinjector with and without the sleeve attached.

Table 2 Benefits Of Using The Sleeve With The Enbrel^® MyClic^®

Benefit	Number (%) Of Participants, N = 24
Better grip	19 (79.2)
Better feeling of control	13 (54.2)
Easier	11 (45.8)
Greater confidence	6 (25.0)
Not having to depress the button	4 (16.7)
None	3 (12.5)

Notes: Patients could select one or more benefits from the following list: better grip, better feeling of control, easier, greater confidence, other, none. All participants who selected “other” stated that the benefit was not having to depress the activation button.